Crinetics Pharmaceuticals's top three insider shareholders as of September 29, 2026 are Advisors Llc Perceptive (TenPercentOwner, 5.32Mn shares), Ajay Madan (Chief Development Officer, 177.00K shares), Stephen F. Betz (Chief Scientific Officer, 123.58K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Advisors Llc Perceptive | TenPercentOwner | 0 | 5,321,032 | 5,321,032 | 87.3% | 18 Apr, 2022 |
| 2 | Ajay Madan | Chief Development Officer | 176,995 | 0 | 176,995 | 2.9% | 02 Mar, 2022 |
| 3 | Stephen F. Betz | Chief Scientific Officer | 123,583 | 0 | 123,583 | 2.0% | 17 Feb, 2022 |
| 4 | Wendall Wierenga | Director | 116,146 | 0 | 116,146 | 1.9% | 13 Jun, 2025 |
| 5 | Marc Wilson | Cfo | 111,092 | 0 | 111,092 | 1.8% | 30 Sep, 2024 |
| 6 | Jeff E. Knight | Chief Dev. Operating Officer | 105,289 | 0 | 105,289 | 1.7% | 10 Apr, 2026 |
| 7 | Dana Pizzuti | Chief Med And Dev Officer | 66,837 | 0 | 66,837 | 1.1% | 03 Dec, 2025 |
| 8 | Alan Seth Krasner | Chief Medical Officer | 43,210 | 0 | 43,210 | 0.7% | 19 Oct, 2023 |
| 9 | James Hassard | Chief Commercial Officer | 29,259 | 0 | 29,259 | 0.5% | 09 Jul, 2024 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 01 Sep, 2026 | Isabel Kalofonos | Chief Commercial Officer | Disposed D | 1,669 | $85.00 | $141.87K | 34,000 | Direct |
| 01 Sep, 2026 | Tobin Schilke | Chief Financial Infra. Ofcr. | Disposed D | 7,956 | $85.00 | $676.26K | 71,471 | Direct |
| 01 Sep, 2026 | Camille L Bedrosian | Director | Disposed D | 16,300 | $85.00 | $1.39Mn | 5,925 | Direct |
| 01 Sep, 2026 | Richard Scott Struthers | President Ceo | Disposed D | 248,043 | $85.00 | $21.08Mn | 176,663 | Direct |
| 01 Sep, 2026 | Weston Nichols | Director | Disposed D | 16,300 | $85.00 | $1.39Mn | 5,925 | Direct |
| 01 Sep, 2026 | Matthew K Fust | Director | Disposed D | 22,836 | $85.00 | $1.94Mn | 5,925 | Direct |
| 01 Sep, 2026 | Stephanie Okey | Director | Disposed D | 6,400 | $85.00 | $544.00K | 5,925 | Direct |
| 01 Sep, 2026 | Stephen F. Betz | Chief Scientific Officer | Disposed D | 58,286 | $85.00 | $4.95Mn | 79,650 | Direct |
| 01 Sep, 2026 | Coelho Rogerio Vivaldi | Director | Disposed D | 13,300 | $85.00 | $1.13Mn | 5,925 | Direct |
| 01 Sep, 2026 | Wendell Wierenga | Director | Disposed D | 116,146 | $85.00 | $9.87Mn | 5,925 | Direct |
| 01 Sep, 2026 | Caren Deardorf | Director | Disposed D | 16,300 | $85.00 | $1.39Mn | 5,925 | Direct |
| 01 Sep, 2026 | Richard Scott Struthers | President Ceo | Disposed D | 1,000 | $85.00 | $85.00K | 0 | Indirect |
| 01 Sep, 2026 | Caren Deardorf | Director | Disposed D | 5,925 | $85.00 | $503.63K | 0 | Direct |
| 01 Sep, 2026 | Camille L Bedrosian | Director | Disposed D | 5,925 | $85.00 | $503.63K | 0 | Direct |
| 01 Sep, 2026 | Isabel Kalofonos | Chief Commercial Officer | Disposed D | 34,000 | $85.00 | $2.89Mn | 0 | Direct |
| 01 Sep, 2026 | Matthew K Fust | Director | Disposed D | 5,925 | $85.00 | $503.63K | 0 | Direct |
| 01 Sep, 2026 | Weston Nichols | Director | Disposed D | 5,925 | $85.00 | $503.63K | 0 | Direct |
| 01 Sep, 2026 | Coelho Rogerio Vivaldi | Director | Disposed D | 5,925 | $85.00 | $503.63K | 0 | Direct |
| 01 Sep, 2026 | Stephanie Okey | Director | Disposed D | 5,925 | $85.00 | $503.63K | 0 | Direct |
| 01 Sep, 2026 | Wendell Wierenga | Director | Disposed D | 5,925 | $85.00 | $503.63K | 0 | Direct |